Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene complementation using myoblast transfer into fetal muscle

M M Sopper1, S D Hauschka, E Hoffman

  • 1Department of Cell Biology and Physiology, University of Pittsburgh School of Medicine, PA 15261, USA.

Gene Therapy
|March 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum: Measurement of the Sixth-Order Cumulant of Net-Proton Multiplicity Distributions in Au+Au Collisions at sqrt[s_{NN}]=27, 54.4, and 200 GeV at RHIC [Phys. Rev. Lett. 127, 262301 (2021)].

Physical review letters·2025
Same author

Erratum: Nonmonotonic Energy Dependence of Net-Proton Number Fluctuations [Phys. Rev. Lett. 126, 092301 (2021)].

Physical review letters·2025
Same author

Erratum: Global Polarization of Ξ and Ω Hyperons in Au+Au Collisions at sqrt[s_{NN}]=200  GeV [Phys. Rev. Lett. 126, 162301 (2021)].

Physical review letters·2023
Same author

Collision-System and Beam-Energy Dependence of Anisotropic Flow Fluctuations.

Physical review letters·2023
Same author

High content analysis of in vitro alveolar macrophage responses can provide mechanistic insight for inhaled product safety assessment.

Toxicology in vitro : an international journal published in association with BIBRA·2022
Same author

Evidence for Nonlinear Gluon Effects in QCD and Their Mass Number Dependence at STAR.

Physical review letters·2022
Same journal

Improving the precision of AAV lung gene therapy for SP-B deficiency using computationally derived lung-specific promoters.

Gene therapy·2026
Same journal

Recent advancements in improving cross-species applicability of bioengineered AAV capsids.

Gene therapy·2026
Same journal

Assessment of F/HN-pseudotyped lentiviral vector following intravenous delivery to mice.

Gene therapy·2026
Same journal

Applications of genome editing technologies in the treatment of human diseases.

Gene therapy·2026
Same journal

High resolution ES-DMA quantifies AAV capsid DNA content by electrical mobility to mass correlation.

Gene therapy·2026
Same journal

AAV8-mediated mouse/human PROC expression rescues thrombophilia in hereditary protein C-deficient mice.

Gene therapy·2026
See all related articles

Myoblast transfer into fetal mice improves gene therapy for genetic muscle disorders. This technique creates more mosaic myofibers, effectively delivering therapeutic genes before immune responses develop.

Area of Science:

  • Regenerative Medicine
  • Developmental Biology
  • Muscle Biology

Background:

  • Myoblast transfer therapy is explored for primary myopathies and augmenting diminished gene products.
  • Previous studies faced challenges with neonatal or adult muscle transfer.

Purpose of the Study:

  • To describe a novel technique for myoblast injection into fetal mice.
  • To evaluate the efficacy of fetal myoblast transfer for gene therapy.

Main Methods:

  • Injection of myoblasts into limb muscles of normal and dystrophin-deficient (mdx) fetal mice.
  • Utilizing tetraploid MM14 myoblasts as a permanent cytological marker.
  • Assessing dystrophin expression in mosaic myofibers via immunohistochemistry.

Main Results:

Related Experiment Videos

  • Successful myoblast injection into fetal mice without significant interference with development.
  • Increased formation of mosaic myofibers compared to neonatal or adult transfers.
  • Demonstrated dystrophin expression in mosaic myofibers of mdx fetuses.

Conclusions:

  • Fetal myoblast transfer is a viable technique for gene therapy in genetic muscle disorders.
  • This method facilitates the evaluation of myoblasts as vectors for fetal gene deficiencies.
  • The technique shows promise for treating conditions manifested during fetal development.